Next Generation Sequencing (ICGex)

Access specialist infrastructure, technologies and expert teams without building them internally.

Scientific visual associated with Next Generation Sequencing (ICGex)
Platforms expertise — Curie Cancer
01Carnot instituteCurie Cancer
02Development stageDiscovery / target validation
03Main expertisePlatforms
04Relevant fieldsAll fields

Offer overview

What this offer helps you achieve

Access specialist infrastructure, technologies and expert teams without building them internally.

Scientific and technical scope

The platform provides a wide range of applications in genomics, transcriptomics and epigenetics at both population and single cell levels. We provide technical and scientific support for experimental design and sequencing strategies. We are also involved in the development of innovative approaches such as the implementation of new high-potential technologies especially in single cell analysis and long read sequencing (PacBio and Oxford Nanopore). The platform is ISO9001 and NFX50-900 certified.
01

Capabilities mobilised

Therapeutic areasExpert adviceTherapeutic target discoveryPlatforms
02

Application fields

All fields

Discuss this offer

Could this capability strengthen your R&D programme?

Present your scientific, technical or clinical need and identify the most relevant route to collaboration.